Profile
| Metric | Value |
|---|---|
| Full Name | Medpace Holdings, Inc. |
| Ticker | NASDAQ: MEDP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | medpace.com |
| Employees | 6,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $620.59 | |
| Price, 1D Change | +3.02% | |
| Market Cap | $17B | |
| - | ||
| PE Ratio | 43.40 | |
| Beta | 0.98 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +11.84% | |
| EPS | $12.63 | |
| EPS, 1Y Change | +42.30% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $12.63 | |
| EPS Estimate | $15.12 | |
| EPS Est. Change | +19.70% | |
| Revenue | $2.11B | |
| Revenue Estimate | $2.51B | |
| Revenue Est. Change | +19.07% | |
| Current Price | $620.59 | |
| Price Target | - | $567.50 |
| Price Tgt. Change | - | -8.55% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.63 | $8.88 | +2.85% | |
| $12.29 | $12.63 | +2.77% | |
| $15.12 | N/A | +19.70% | |
| $16.51 | N/A | +30.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.89B | $1.89B | +0.01% | |
| $2.11B | $2.11B | +0.08% | |
| $2.51B | N/A | +19.07% | |
| $2.81B | N/A | +33.39% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +79.79% | |
| Price, 3Y | +170.83% | |
| Market Cap, 1Y | +65.33% | |
| Market Cap, 3Y | +145.37% | |
| Revenue, 1Y | +11.84% | |
| Revenue, 3Y | +84.62% | |
| EPS, 1Y | +42.30% | |
| EPS, 3Y | +162.48% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $620.59 | |
| SMA 200 | $449.12 | |
| SMA 200 vs Price | -27.63% | |
| SMA 50 | $584.03 | |
| SMA 50 vs Price | -5.89% | |
| Beta | 0.98 | |
| ATR | $17.76 | |
| 14-Day RSI | 63.94 | |
| 10-Day Volatility | 25.04% | |
| 1-Year Volatility | 65.66% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.11B | |
| EPS | $12.63 | |
| Gross Profit | $627.05M | |
| Gross Margin | 29.73% | |
| Operating Profit | $446.87M | |
| Operating Margin | 21.19% | |
| Net Income | $404.34M | |
| Net Margin | 19.17% | |
| EBITDA | $476.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.18 | |
| Current Ratio | 0.93 | |
| Quick Ratio | 0.93 | |
| Interest Coverage | - | |
| F-Score | 7 | |
| Altman Z-Score | 9.89 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 43.40 | |
| PS Ratio | 7.41 | |
| PB Ratio | 59.53 | |
| EV/EBITDA | 32.38 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $825.55M | |
| Cash & Equivalents | $669.44M | |
| Total Assets | $2.10B | |
| Current Assets | $1.03B | |
| Total Liabilities | $1.28B | |
| Current Liabilities | $1.10B | |
| Total Debt | $149.52M | |
| Short Term Debt | $23.29M | |
| Accounts Payable | $32.53M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.70B | |
| Operating Expenses | $180.18M | |
| Cost Of Goods Sold | $1.48B | |
| SG&A | $0.00 | |
| D&A | $29.25M | |
| Interest Expense | $0.00 | |
| Income Tax | $71.54M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $608.82M | |
| CFI | -$28.31M | |
| CFF | -$154.01M | |
| Capex | $36.55M | |
| Free Cash Flow | $572.27M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| BMO Capital | ||
| Truist Securities | → | |
| TD Cowen | → | |
| Mizuho | → | |
| Barclays | → | |
| Mizuho | → | |
| Barclays | → | |
| Jefferies | → | |
| Rothschild & Co | → |
Analyst sentiment
Institutional ownership
Screeners with MEDP
FAQ
What is the ticker symbol for Medpace Holdings, Inc.?
The ticker symbol for Medpace Holdings, Inc. is NASDAQ:MEDP
Does Medpace Holdings, Inc. pay dividends?
No, Medpace Holdings, Inc. does not pay dividends
What sector is Medpace Holdings, Inc. in?
Medpace Holdings, Inc. is in the Healthcare sector
What industry is Medpace Holdings, Inc. in?
Medpace Holdings, Inc. is in the Diagnostics & Research industry
What country is Medpace Holdings, Inc. based in?
Medpace Holdings, Inc. is headquartered in United States
When did Medpace Holdings, Inc. go public?
Medpace Holdings, Inc. initial public offering (IPO) was on August 11, 2016
Is Medpace Holdings, Inc. in the S&P 500?
No, Medpace Holdings, Inc. is not included in the S&P 500 index
Is Medpace Holdings, Inc. in the NASDAQ 100?
No, Medpace Holdings, Inc. is not included in the NASDAQ 100 index
Is Medpace Holdings, Inc. in the Dow Jones?
No, Medpace Holdings, Inc. is not included in the Dow Jones index
When was Medpace Holdings, Inc. last earnings report?
Medpace Holdings, Inc.'s most recent earnings report was on October 22, 2025
When does Medpace Holdings, Inc. report earnings?
The next expected earnings date for Medpace Holdings, Inc. is February 9, 2026
Data Sources & References
- MEDP Official Website www.medpace.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1668397/000166839725000110/0001668397-25-000110-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1668397/000166839725000017/0001668397-25-000017-index.htm
- MEDP Profile on Yahoo Finance finance.yahoo.com/quote/MEDP
- MEDP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/medp